CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 105 enrolled
Drug / intervention
senofilcon A contact lensesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03319212
NCT03319212N/ACompleted
CompareCT.gov

Clinical Characterization of Symptomatic Populations

Johnson & Johnson Vision Care, Inc.·interventional·Posted Oct 24, 2017·Updated Oct 15, 2019

In Brief

A clinical study evaluating senofilcon A contact lenses for Ametropia. Completed, enrolled 105 participants across 2 sites in 2 countries.

Detailed Summary

This is an unmasked, non-randomized, single arm, stratified, dispensing investigation of symptomatic and asymptomatic subject populations. Subjects will be assigned to a single study lens type to be worn bilaterally for approximately 4 weeks followed by no contact lens wear for 1 week.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 24, 2017
Enrollment StartSep 29, 2017
Primary CompletionAug 15, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.7 years ago

Interventions

senofilcon A contact lensesdevice

Senofilcon A Daily Disposable Contact Lenses